1. Promising antimalarial hits from phenotypic screens: a review of recently-described multi-stage actives and their modes of action
   Annie-Peiyuan Luo et al, 2023, Frontiers in Cellular and Infection Microbiology CrossRef
2. Identification of neutrophil extracellular trap-driven gastric cancer heterogeneity and C5AR1 as a therapeutic target
   Jing Zhao et al, 2024, Acta Biochimica et Biophysica Sinica CrossRef
3. Research progress in protein microarrays: Focussing on cancer research
   Guang Chen et al, 2023, PROTEOMICS – Clinical Applications CrossRef
4. A-Review on Anticancer Agents: Conventional Drugs and Novel Target Specific Inhibitors
   Shivkant Patel et al, 2023, Oriental Journal Of Chemistry CrossRef
5. Construction of a prognostic 6-gene signature for breast cancer based on multi-omics and single-cell data
   Zeyu Xing et al, 2023, Frontiers in Oncology CrossRef
6. Enhancing breast cancer outcomes with machine learning-driven glutamine metabolic reprogramming signature
   Xukui Li et al, 2024, Frontiers in Immunology CrossRef
7. A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencing
   Xiaoqing Xiang et al, 2023, Frontiers in Immunology CrossRef
8. Apatinib inhibits the proliferation of gastric cancer cells via the AKT/GSK signaling pathway in vivo
   Yi Chen et al, 2021, Aging CrossRef
9. A polo-like kinase 1 inhibitor enhances erastin sensitivity in head and neck squamous cell carcinoma cells in vitro
   Xiangping Wu et al, 2024, Cancer Chemotherapy and Pharmacology CrossRef
10. PLK1 inhibition impairs erythroid differentiation
    Peijun Jia et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
11. Present and Future Perspective on PLK1 Inhibition in Cancer Treatment
    Michela Chiappa et al, 2022, Frontiers in Oncology CrossRef